SPTX (SPTX)
24.82
+1.21 (5.12%)
Upcoming Events
Latest Headlines
Jones Trading Starts Seaport Therapeutics (SPTX) at Buy
August 25, 2026 4:17 PM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Seaport Therapeutics (SPTX)
August 20, 2026 6:58 AM - StreetInsider
Form SCHEDULE 13G Seaport Therapeutics, Filed by: PureTech LYT, Inc.
August 14, 2026 4:35 PM - SEC Filing
Seaport Therapeutics (SPTX) PT Lowered to $44 at JPMorgan
August 5, 2026 8:17 AM - StreetInsider
Form SCHEDULE 13G Seaport Therapeutics, Filed by: Zohar Daphne
August 5, 2026 8:06 AM - SEC Filing
Form SCHEDULE 13G Seaport Therapeutics, Filed by: PAUL STEVEN M
August 5, 2026 6:06 AM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Seaport Therapeutics (SPTX)
August 4, 2026 6:54 AM - StreetInsider
Form 10-Q Seaport Therapeutics, For: Jun 30
August 3, 2026 7:12 AM - SEC Filing
Form 8-K Seaport Therapeutics, For: Aug 03
August 3, 2026 7:03 AM - SEC Filing
Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
August 3, 2026 7:00 AM - BizWire
H.C. Wainwright Starts Seaport Therapeutics (SPTX) at Buy
July 15, 2026 6:04 AM - StreetInsider
Form 4 Seaport Therapeutics, For: Jun 22 Filed by: HOMBACH ROBERT J.
June 24, 2026 6:05 AM - SEC Filing
Stifel Reiterates Buy Rating on Seaport Therapeutics (SPTX)
June 9, 2026 3:34 AM - StreetInsider
Seaport Therapeutics reports positive phase 1 data for GlyphAgo anxiety drug
June 9, 2026 2:00 AM - StreetInsider
PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
June 9, 2026 2:00 AM - BizWire
Form 10-Q Seaport Therapeutics, For: Mar 31
June 8, 2026 7:16 AM - SEC Filing
Form 8-K Seaport Therapeutics, For: Jun 08
June 8, 2026 7:12 AM - SEC Filing
Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
June 8, 2026 7:05 AM - BizWire
Seaport Therapeutics reports positive phase 1 data for anxiety drug candidate
June 8, 2026 7:00 AM - StreetInsider
Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
June 8, 2026 7:00 AM - BizWire
Full Article List
